Literature DB >> 7290105

Idiopathic torticollis: sternocleidomastoid myopathy and accessory neuropathy.

H B Sarnat, R T Morrissy.   

Abstract

Biopsies of the two heads of the sternocleidomastoid muscle were studied in 9 children with idiopathic torticollis, from 8 months to 17 years of age, who were undergoing surgical release of the sternal and clavicular attachments on the side of the contracture. Extensive fibrosis involved mainly the sternal head. Nonspecific myopathic changes, also mainly in the sternal head, included cytoarchitectural alterations of muscle fibers, necrosis, and focal inflammation. Histochemical type grouping and grouped atrophy were extensive in some cases and present in all except one, but the clavicular head was predominantly involved. Denervation and reinnervation are common chronic features in idiopathic torticollis, probably secondary to entrapment neuropathy: the accessory nerve reaches the clavicular head by passing through the sternal head. Separate arterial supplies predispose to ischemia in the sternal head, resulting in focal myopathy and fibrosis.

Entities:  

Mesh:

Year:  1981        PMID: 7290105     DOI: 10.1002/mus.880040505

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  3 in total

1.  Idiopathic torticollis. Torticollis in white Pekin ducks.

Authors:  P Gopalakrishnakone
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

2.  Prognostic Factors in Recurrent Congenital Muscular Torticollis.

Authors:  C Chotigavanichaya; P Phongprapapan; J Wongcharoenwatana; P Eamsobhana; T Ariyawatkul; K Kaewpornsawan
Journal:  Malays Orthop J       Date:  2021-03

3.  A Marine Terpenoid, Heteronemin, Induces Both the Apoptosis and Ferroptosis of Hepatocellular Carcinoma Cells and Involves the ROS and MAPK Pathways.

Authors:  Wen-Tsan Chang; Yung-Ding Bow; Pei-Jung Fu; Chia-Yang Li; Chang-Yi Wu; Yi-Hua Chang; Yen-Ni Teng; Ruei-Nian Li; Mei-Chin Lu; Yi-Chang Liu; Chien-Chih Chiu
Journal:  Oxid Med Cell Longev       Date:  2021-01-04       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.